High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications

[1]  H. Litt,et al.  FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[2]  I. Bhan,et al.  Ergocalciferol and cholecalciferol in CKD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  M. Wolf,et al.  UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE , 2012, Kidney international.

[4]  L. Hsiao,et al.  Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23 , 2012, Circulation.

[5]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[6]  S. Goldstein,et al.  Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients , 2011, Pediatric Nephrology.

[7]  A. Kırkpantur,et al.  Plasma fibroblast growth factor‐23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[8]  M. Kemper,et al.  Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. , 2010, Kidney international.

[9]  S. Goldstein,et al.  Malnutrition‐inflammation‐coronary calcification in pediatric patients receiving chronic hemodialysis , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[10]  M. Kuro-o.  Overview of the FGF23-Klotho axis , 2010, Pediatric Nephrology.

[11]  H. Melhus,et al.  Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. , 2009, Atherosclerosis.

[12]  M. Razzaque,et al.  The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis , 2009, Nature Reviews Endocrinology.

[13]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[14]  Thomas J. Wang,et al.  Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease , 2009, Circulation.

[15]  S. Kuruğoğlu,et al.  Progression of coronary calcification in pediatric chronic kidney disease stage 5 , 2009, Pediatric Nephrology.

[16]  M. Wolf,et al.  Phosphorus binders and survival on hemodialysis. , 2009, Journal of the American Society of Nephrology : JASN.

[17]  C. Chazot,et al.  Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  S. Mundra,et al.  Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis , 2009 .

[19]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[20]  L. Schurgers,et al.  Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis , 2008, Circulation.

[21]  M. Taal,et al.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[22]  D. Milford,et al.  Mineral metabolism and vascular damage in children on dialysis. , 2007, Journal of the American Society of Nephrology : JASN.

[23]  M. Joffe,et al.  Determinants of Coronary Artery Calcification Progression in Renal Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  P. Raggi,et al.  Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. , 2007, Kidney international.

[25]  K. Hruska,et al.  Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. , 2007, Journal of the American Society of Nephrology : JASN.

[26]  H. Oflaz,et al.  Coronary artery calcifications in children with end-stage renal disease , 2006, Pediatric Nephrology.

[27]  P. Raggi,et al.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. , 2005, Kidney international.

[28]  J. Kopple.  The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. , 2005, The American journal of clinical nutrition.

[29]  N. Fineberg,et al.  Natural history of vascular calcification in dialysis and transplant patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  J. Craig,et al.  Long-term survival of children with end-stage renal disease. , 2004, The New England journal of medicine.

[31]  P. Raggi,et al.  Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. , 2004, The Journal of heart valve disease.

[32]  E. Lonn,et al.  Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  R. Wolfe,et al.  Cardiovascular mortality in children and young adults with end-stage kidney disease. , 2002, The Journal of pediatrics.

[34]  P. Raggi,et al.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.

[35]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[36]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[37]  A. Levey,et al.  Cardiovascular disease and chronic renal disease: a new paradigm. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.